The most recent full-year data show a widening gap between the use of European and U.S. facilities, with the first half of 2026 continuing that trend, finds analytics firm.
Go beyond similarity in this webchat with a Thermo Fisher Scientific expert on how a p-value-based multivariate residual approach verifies pharmaceutical raw materials.
